As of the latest SEC filings, Sarepta Therapeutics, Inc. (SRPT) is held by 277 institutional funds. The largest fund shareholder is iShares Core S&P Small-Cap ETF (IJR), holding an estimated $136,848,922.88 in market value, representing 0.15% of its portfolio.
Funds holding Sarepta Therapeutics, Inc. (SRPT)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- SRPT
- CIK:
- 0000873303
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
IJR
iShares Core S&P Small-Cap ETF
|
ETF | BlackRock / iShares | 0.15% | $136,848,922.88 | 6,289,013 | Mar 31, 2026 | May 26, 2026 |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
ETF | First Trust | 3.24% | $73,643,325.44 | 3,384,344 | Mar 31, 2026 | May 28, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $69,899,756.80 | 3,212,305 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.89% | $66,520,972.80 | 3,057,030 | Mar 31, 2026 | May 28, 2026 |
|
NAESX
VANGUARD SMALL-CAP INDEX FUND
|
ETF | Vanguard | 0.03% | $50,337,756.16 | 2,313,316 | Mar 31, 2026 | May 28, 2026 |
|
VISGX
VANGUARD SMALL-CAP GROWTH INDEX FUND
|
ETF | Vanguard | 0.07% | $28,119,425.28 | 1,292,253 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.03% | $25,443,228.16 | 1,169,266 | Mar 31, 2026 | May 28, 2026 |
|
FGSAX
Federated Hermes MDT Mid Cap Growth Fund
|
MF | Federated Hermes | 0.39% | $24,923,077.92 | 1,193,634 | Apr 30, 2026 | Jun 23, 2026 |
|
THQ
abrdn Healthcare Opportunities Fund
|
CEF | abrdn / Aberdeen | 2.90% | $20,911,729.92 | 961,017 | Mar 31, 2026 | May 29, 2026 |
|
SPSM
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF
|
ETF | State Street (SPDR) | 0.15% | $20,576,103.68 | 945,593 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.80% | $20,488,345.60 | 941,560 | Mar 31, 2026 | May 29, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.20% | $16,093,848.32 | 739,607 | Mar 31, 2026 | May 28, 2026 |
|
VTSIX
VANGUARD TAX-MANAGED SMALL-CAP FUND
|
MF | Vanguard | 0.16% | $15,221,424.64 | 699,514 | Mar 31, 2026 | May 28, 2026 |
|
VSEQX
VANGUARD STRATEGIC EQUITY FUND
|
MF | Vanguard | 0.13% | $12,650,437.12 | 581,362 | Mar 31, 2026 | May 28, 2026 |
|
PASVX
T. Rowe Price Small-Cap Value Fund, Inc.
|
MF | T. Rowe Price | 0.13% | $12,215,498.24 | 561,374 | Mar 31, 2026 | May 28, 2026 |
|
IWP
iShares Russell Mid-Cap Growth ETF
|
ETF | BlackRock / iShares | 0.06% | $12,004,578.56 | 551,681 | Mar 31, 2026 | May 28, 2026 |
|
IJT
iShares S&P Small-Cap 600 Growth ETF
|
ETF | BlackRock / iShares | 0.18% | $11,998,289.92 | 551,392 | Mar 31, 2026 | May 28, 2026 |
|
FXH
First Trust Health Care AlphaDEX Fund
|
ETF | First Trust | 1.25% | $10,894,348.80 | 521,760 | Apr 30, 2026 | Jun 23, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $9,217,497.20 | 549,970 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.62% | $9,058,970.88 | 416,313 | Mar 31, 2026 | May 29, 2026 |
|
IJS
iShares S&P Small-Cap 600 Value ETF
|
ETF | BlackRock / iShares | 0.12% | $8,736,313.60 | 401,485 | Mar 31, 2026 | May 26, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.04% | $8,547,884.92 | 510,017 | Feb 28, 2026 | Apr 24, 2026 |
|
IWR
iShares Russell Mid-Cap ETF
|
ETF | BlackRock / iShares | 0.02% | $8,223,256.32 | 377,907 | Mar 31, 2026 | May 28, 2026 |
|
FSMDX
Fidelity Mid Cap Index Fund
|
MF | Fidelity | 0.02% | $7,650,181.44 | 366,388 | Apr 30, 2026 | Jun 26, 2026 |
|
SLYG
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF
|
ETF | State Street (SPDR) | 0.18% | $7,337,602.56 | 337,206 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)